Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines

Clinical trial NCT06104345 · COMPLETED

Trial details

NCT number: NCT06104345
Sponsor: Helsinki University Central Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Vaccine-Preventable Diseases Typhoid Fever Cholera

Start date: 2023-10-25
Primary completion: 2024-06-26
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.